Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

Abstract

We conducted a double-blind, placebo-controlled trial of oral azidothymidine (AZT) in 282 patients with the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. Although significant clinical benefit was documented (N Engl J Med 1987; 317:185-91), serious adverse reactions, particularly bone marrow suppression, were observed. Nausea, myalgia, insomnia, and severe headaches were reported more frequently by recipients of AZT; macrocytosis developed within weeks in most of the AZT group. Anemia with hemoglobin levels below 7.5 g per deciliter developed in 24 percent of AZT recipients and 4 percent of placebo recipients (P less than 0.001). Twenty-one percent of AZT recipients and 4 percent of placebo recipients required multiple red-cell transfusions (P less than 0.001). Neutropenia (less than 500 cells per cubic millimeter) occurred in 16 percent of AZT recipients, as compared with 2 percent of placebo recipients (P less than 0.001). Subjects who entered the study with low CD4 lymphocyte counts, low serum vitamin B12 levels, anemia, or low neutrophil counts were more likely to have hematologic toxic effects. Concurrent use of acetaminophen was also associated with a higher frequency of hematologic toxicity. Although a subset of patients tolerated AZT for an extended period with few toxic effects, the drug should be administered with caution because of its toxicity and the limited experience with it to date.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm198707233170401

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 18 references

Research works printed but not linked: 5

  1. Furman PA, St. Clair M, Weinhold K, et al. Selective inhibition of HTLV-III by BW A509U. In: Program and abstracts of the Twenty-fifth Inter-science Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, October 1985. American Society of Microbiology, 1985:172. abstract.
  2. SAS user's guide: statistics 1982 edition. Cary, N.C.: SAS Institute, 1982.
  3. Mantel, 1963, J Am Stat Assoc, 58, 690
  4. 1982, MMWR, 31, 507
  5. 1982, MMWR, 32, 688

Cited by

See all 2,995

Metadata

Authors
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., King, D., & The AZT Collaborative Working Group
Venue
New England Journal of Medicine
Published
1987-07-23
Volume
317
Issue
4
Pages
185-191
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2333399282
Cited by
2,995
References
18
Citations by year
2026: 18 · 2025: 18 · 2024: 20 · 2023: 25 · 2022: 24 · 2021: 36 · 2020: 41 · 2019: 40 · 2018: 26 · 2017: 33 · 2016: 26 · 2015: 47 · 2014: 38 · 2013: 36 · 2012: 45
FWCI
218.73
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
zidovudine, AIDS, AIDS-related complex, antiretroviral therapy, hematologic toxicity, myelosuppression, anemia, neutropenia, macrocytosis, paracetamol, CD4 count, vitamin B12, adverse drug reactions
MeSH terms
Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Antiviral Agents, Clinical Trials as Topic, Double-Blind Method, Female, Humans, Male, Opportunistic Infections, Pneumonia, Pneumocystis, Random Allocation, Sarcoma, Kaposi, Thymidine, Zidovudine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex. https://app.cochat.ai/papers/10.1056/nejm198707233170401
The paper
Fischl, M. A., Richman, D. D., Grieco, M. H., Gottlieb, M. S., Volberding, P. A., Laskin, O. L., Leedom, J. M., Groopman, J. E., Mildvan, D., Schooley, R. T., Jackson, G. G., Durack, D. T., King, D., & The AZT Collaborative Working Group. (1987). The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex. New England Journal of Medicine. https://doi.org/10.1056/nejm198707233170401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.